NCT03257813View on ClinicalTrials.gov

Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK)

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

March 1, 2017

Study Completion Date

June 18, 2017

Conditions
Primary Open Angle GlaucomaOcular Hypertension
Interventions
DRUG

PRO-122

1 drop every 12 hours for 30 days of alternating treatment with 30 days

DRUG

Krytantek Ofteno®

1 drop every 12 hours for 30 days of alternating treatment with 30 days

All Listed Sponsors
lead

Laboratorios Sophia S.A de C.V.

INDUSTRY

NCT03257813 - Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK) | Biotech Hunter | Biotech Hunter